331. Deputy Róisín Shortall asked the Minister for Health if he intends to conduct a cost benefit analysis into subsidising essential asthma medications which are excluded from the long-term illness scheme as a means of reducing unscheduled asthma-related GP, ED visits and hospital admissions (details supplied); and if he will make a statement on the matter. [45896/23]

Summary

331. Deputy Róisín Shortall asked the Minister for Health if he intends to conduct a cost benefit analysis into subsidising essential asthma medications which are excluded from the long-term illness scheme as a means of reducing unscheduled asthma-related GP, ED visits and hospital admissions (details supplied); and if he will make a statement on the matter. [45896/23]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 19 October 2023

   Medicinal Products

   331. Deputy Róisín Shortall asked the Minister for Health if he intends to conduct a cost benefit analysis into subsidising essential asthma medications which are excluded from the long-term illness scheme as a means of reducing unscheduled asthma-related GP, ED visits and hospital admissions (details supplied); and if he will make a statement on the matter. [45896/23]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 19 October 2023

  ViewDownloadOpen at official source

Sponsors

• Shortall, Róisín. · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.